Hendrikus J. Dubbink

Erasmus MC — Netherlands

Medicine · Health Sciences

46h-index7.6kcitations220works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(86), Cancer Genomics and Diagnostics(63), Radiomics and Machine Learning in Medical Imaging(53), Genetic factors in colorectal cancer(35), Lung Cancer Treatments and Mutations(32)

Publications216 total

Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial
The Lancet Oncology·2025Open Access
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study
Lung Cancer·2025Open Access
Analytical Validation of a Pan-Cancer Next-Generation Sequencing Assay for In-House Liquid Biopsy Testing
Journal of Molecular Diagnostics·2025Open Access
Yield of next-generation sequencing in diagnostic work up of suspicious biliary strictures
Endoscopy International Open·2025Open Access
Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker study
EClinicalMedicine·2025· 2 citedOpen Access
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
Nature Reviews Clinical Oncology·2025· 7 citedOpen Access
Analysis of comprehensive genomic profiling of solid tumors with a novel assay for broad analysis in clinical diagnostics
Molecular Oncology·2025· 1 citedOpen Access
The Clinical Benefit of Routine Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer for the Detection of Prognostic Co-Mutations – a Multicenter Next Generation Sequencing Study
SSRN Electronic Journal·2025Open Access
Author response for "Analysis of comprehensive genomic profiling of solid tumors with a novel assay for broad analysis in clinical diagnostics"
2024
Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy
ESMO Open·2024· 3 citedOpen Access
Analytical Validation of a Pan-Cancer NGS Assay for In-House Liquid Biopsy Testing: An International Multicenter Study
2024· 2 citedOpen Access
Supplementary Figure S1 from Differences in the Prognostic Role of Age, Extent of Resection, and Tumor Grade between Astrocytoma IDHmt and Oligodendroglioma: A Single-Center Cohort Study
2024Open Access
Data from Differences in the Prognostic Role of Age, Extent of Resection, and Tumor Grade between Astrocytoma IDHmt and Oligodendroglioma: A Single-Center Cohort Study
2024Open Access
Supplementary Figure S1 from Differences in the Prognostic Role of Age, Extent of Resection, and Tumor Grade between Astrocytoma IDHmt and Oligodendroglioma: A Single-Center Cohort Study
2024Open Access
Data from Differences in the Prognostic Role of Age, Extent of Resection, and Tumor Grade between Astrocytoma IDHmt and Oligodendroglioma: A Single-Center Cohort Study
2024Open Access
A Response to the Letter to the Editor: Comment on “Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRAS(G12C)-Mutated NSCLC Treated With Sotorasib”
Journal of Thoracic Oncology·2024
Letter Regarding “Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib”
Journal of Thoracic Oncology·2024· 3 citedOpen Access
Differences in the Prognostic Role of Age, Extent of Resection, and Tumor Grade between Astrocytoma IDHmt and Oligodendroglioma: A Single-Center Cohort Study
Clinical Cancer Research·2024· 17 cited
Metastatic disease after removal of a renal cell carcinoma smaller than 3 cm in a patient with Birt-Hogg-Dubé syndrome, a case report
Familial Cancer·2024Open Access
Exploring the use of circulating tumor DNA for mutational signature analysis
Lung Cancer·2024
page 1 of 11Next →

Frequent Co-authors

Winand N.M. Dinjens(24), Martin J. van den Bent(23), Johan M. Kros(18), Pim J. French(14), Jan Trapman(11), Marc Sanson(9), Walter Taal(8), Thierry Gorlia(8), Peggy N. Atmodimedjo(8), Alba A. Brandes(7), Pieter Wesseling(7), Maarten M.J. Wijnenga(7), Remko Hersmus(7), Ronald van Marion(6), Marion Smits(6), Arnaud J.P.E. Vincent(6), Ewout W. Steyerberg(6), Roelien H. Enting(5), Brigitta G. Baumert(5), Anna K. Nowak(5)